IRIS
GIORDANO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.361
EU - Europa 27.376
AS - Asia 4.035
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 38
SA - Sud America 30
AF - Africa 14
Totale 68.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.272
GB - Regno Unito 11.342
IE - Irlanda 4.909
CN - Cina 3.404
UA - Ucraina 3.231
FR - Francia 1.803
SE - Svezia 1.789
DE - Germania 1.688
IT - Italia 1.446
FI - Finlandia 731
IN - India 210
VN - Vietnam 184
TR - Turchia 100
CA - Canada 81
BE - Belgio 74
AU - Australia 65
ES - Italia 58
NL - Olanda 52
RU - Federazione Russa 48
EU - Europa 36
IM - Isola di Man 27
JP - Giappone 25
AT - Austria 24
GR - Grecia 22
PL - Polonia 21
HU - Ungheria 19
RO - Romania 15
BR - Brasile 13
HK - Hong Kong 13
NZ - Nuova Zelanda 13
SG - Singapore 12
CY - Cipro 11
EE - Estonia 11
CL - Cile 10
KR - Corea 9
DK - Danimarca 8
IL - Israele 7
IR - Iran 7
RS - Serbia 7
SA - Arabia Saudita 7
BG - Bulgaria 6
ID - Indonesia 6
TW - Taiwan 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
HR - Croazia 5
AL - Albania 4
BD - Bangladesh 4
EG - Egitto 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
IQ - Iraq 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EC - Ecuador 2
LU - Lussemburgo 2
MD - Moldavia 2
ME - Montenegro 2
MK - Macedonia 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
GH - Ghana 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MC - Monaco 1
MS - Montserrat 1
MT - Malta 1
PE - Perù 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 68.932
Salva come PNG Salva come JPEG
Città #
Southend 10.618
Fairfield 6.217
Dublin 4.867
Woodbridge 2.905
Chandler 2.781
Jacksonville 2.689
Ashburn 2.599
Wilmington 2.434
Houston 2.422
Seattle 2.299
Cambridge 2.055
Menlo Park 2.030
Ann Arbor 1.345
Princeton 1.340
Nanjing 932
Siena 624
Beijing 608
San Mateo 517
Boardman 437
San Diego 359
Nanchang 350
Shenyang 219
Düsseldorf 209
Helsinki 209
Dong Ket 182
Tianjin 176
Hebei 162
New York 155
Delhi 147
Kunming 143
Changsha 132
London 127
Jiaxing 117
Norwalk 117
Shanghai 96
Dearborn 90
San Francisco 87
Florence 85
Falls Church 79
Izmir 77
Venezia 76
Brussels 74
Hangzhou 67
Jinan 65
Toronto 65
Zhengzhou 50
Rome 49
Milan 48
Málaga 47
Ningbo 47
Lancaster 45
Tappahannock 43
Fremont 42
Taizhou 36
Lanzhou 32
Mestre 32
Changchun 31
Chicago 30
Redwood City 30
Washington 30
Melbourne 28
Fort Worth 27
Frankfurt am Main 27
Prescot 27
Edinburgh 26
Hounslow 26
Kilburn 26
Philadelphia 25
Amsterdam 24
Paris 24
Vienna 24
Douglas 23
Guangzhou 23
Canberra 20
Phoenix 20
Sezze 20
Fuzhou 19
Budapest 17
Chiswick 17
Scottsdale 16
Lappeenranta 14
Groningen 13
Hefei 13
Islington 12
Los Angeles 12
Tokyo 12
Padova 11
Tallinn 11
Auburn Hills 10
Cagliari 10
Falkenstein 10
New Bedfont 10
Pozza 10
Sydney 10
Berlin 9
Grünheide 9
Naples 9
Napoli 9
Southwark 9
Strovolos 9
Totale 54.647
Salva come PNG Salva come JPEG
Nome #
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. 377
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells 252
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 246
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 239
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 230
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. 217
Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation 213
The zebrafish as a model for nociception studies. 208
New players in ovarian cancer. 207
Effect of rMnSOD on Sodium Reabsorption in Renal Proximal Tubule in Ochratoxin A—Treated Rats 197
NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer 196
An Intrinsically Disordered Region of the Acetyltransferase p300 with Similarity to Prion-Like Domains Plays a Role in Aggregation 192
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 192
Study of viral integration of HPV-16 in young patients with LSIL. 191
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. 191
Triple negative breast cancer: Looking for the missing link between biology and treatments 189
Zebrafish Tmem230a cooperates with the Delta/Notch signaling pathway to modulate endothelial cell number in angiogenic vessels 187
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 185
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 184
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 182
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma 181
Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro 181
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino 181
SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment. 180
Dissecting Pin1 and phospho-pRb regulation 178
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs 177
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 177
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 175
Virtual Reality in Health System: Beyond Entertainment. A Mini-Review on the Efficacy of VR During Cancer Treatment 175
Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? 173
The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records. 171
Translational Research and Plasma Proteomic in Cancer 171
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 171
Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy. 170
Gastroprotective effects of L-Lysine salification of ketoprofen in ethanol-injured gastric mucosa 170
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 167
NSP 5a3a's link to nuclear-cyto proteins B23 and hnRNP-L between normal and aberrant breast cell lines. 166
Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma 166
A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression? 165
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. 165
Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins 165
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 165
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 165
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 164
null 162
”Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor” 161
NONO regulates the intra-S-phase checkpoint in response to UV radiation 161
Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells. 161
Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer 161
Multifaceted Breast Cancer: The Molecular Connection With Obesity 160
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt`s lymphoma cell lines. 160
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 160
2,3,7,8-Tetrachlorodibenzo-p-dioxin modifies expression and nuclear/cytosolic localization of bovine herpesvirus 1 immediate-early protein (bICP0) during infection. 160
"A method of inhibiting cancer cell growth using a vector expressing pRb2/p130." 159
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy 159
A study of quiet eye's phenomenon in the shooting section of "laser run" of modern pentathlon 159
Novel insights in basic and applied stem cell therapy 158
A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients 158
Are RB proteins a potential substrate of Pin1 in the regulation of the cell cycle? 157
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 156
Pin1 and nuclear receptors: A new language? 155
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors 154
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 154
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 153
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives 153
null 153
pRb2/p130 gene overexpression induces astrocyte differentiation 152
Cdk9-55: a new player in muscle regeneration 151
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells 151
Prevention of Nephrotoxicity Induced by Cyclosporine-A: Role of Antioxidants 150
null 150
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 150
The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation 149
The tumor suppressor role of CTCF 148
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease. 148
Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? 148
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 148
Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development 148
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 148
Blood-derived stem cells (BDSCs) plasticity: In vitro hepatic differentiation. 148
null 147
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 147
CDK9 (PITALRE): a multifunctional cdc2-related kinase 147
Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells 147
Anticancer therapeutic strategies based on CDK inhibitors. 146
null 146
" Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing RB2/p130 " 145
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 145
Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes. 145
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 145
”Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor” 144
The Protective Effect of Apocynin on Cyclosporine A-Induced Hypertension and Nephrotoxicity in Rats 144
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 144
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy 144
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 143
Conservative treatment of early endometrial cancer 143
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 143
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model 143
Frequent loss of pRb2/p130 in human ovarian carcinoma. 142
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 142
Totale 16.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195.070 0 0 0 0 0 0 0 0 0 966 2.117 1.987
2019/202015.230 2.029 544 1.279 2.403 1.005 1.118 1.273 1.921 1.280 1.193 303 882
2020/202112.375 452 1.338 379 1.186 435 1.270 541 1.880 1.943 1.108 984 859
2021/20229.041 656 1.047 697 484 522 367 605 349 607 1.021 736 1.950
2022/202310.800 825 446 1.214 1.747 1.143 2.646 122 868 1.040 143 403 203
2023/20245.348 330 166 471 148 196 1.674 2.129 111 33 90 0 0
Totale 69.941